OLMA 8-K 2026-11-10

Olema Pharmaceuticals, Inc. (OLMA) 8-K dated 2026-11-10 — accession 0001193125-26-454403.

Olema Pharmaceuticals, Inc. (OLMA) is a biotechnology company listed on NASDAQ.

OLMA: Olema Oncology Reports Third Quarter 2026 Financial and Operating Resul…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for OLMA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The OLMA SEC hub lists recent forms. The stock page is the research view.